CD274 and glioblastoma: Flow cytometry analysis revealed significantly higher uptake of DiD-labeled siRNA LNPs modified with the anti-PD-L1 antibody in GL261 glioblastoma cells compared with both unmodified and isotype control antibody-modified LNPs (p < 0.05).